Clarifying 'long-term' for protected areas and other effective area-based conservation measures (OECMs): why only 25 years of 'intent' does not qualify

The concept of 'long-term' is a key part of the definitions of both protected areas and other effective area-based conservation measures (OECMs). Draft principles for OECMs in Australia developed by the Australian Government propose a minimum period for OECMs of 25 years, where a landholder is not able to commit to in-perpetuity conservation. The proposal suggests this is consistent with IUCN Guidelines for Privately Protected Areas. As authors of the Guidelines for Privately Protected Areas we contend however that Australia's proposed OECM guideline suggesting 25 years of "intention" to deliver biodiversity outcomes is 'long-term' is not supported by IUCN guidelines. Furthermore for protected areas, Australia has a long-established definition of 'long-term' - specifically a minimum timeframe of 99 years is required if permanent protection is not possible - embedded in both national policy and legal agreements. As national governments rapidly seek to define OECMs in response to the raised ambitions of the Kunming-Montreal Global Biodiversity Framework, there will be increasing interest in what counts towards Target 3. Ultimately, more land managed for conservation is good and all forms of area-based conservation should be encouraged. However, not all forms of area-based conservation qualify for inclusion in Target 3. Long-term intent and outcomes are fundamental, as outlined in the definitions of protected areas and OECMs

The essential role of other effective area-based conservation measures in achieving big bold conservation targets

Continued biodiversity loss has prompted calls for half of the planet to be set aside for nature - including E. O Wilson's "Half-Earth" approach and the Wild Foundation's "Nature Needs Half" initiative. These efforts have provided a necessary wake-up call and drawn welcome global attention for the urgent need for increased action on conserving biodiversity and nature in general. Yet they have also sparked debate within the conservation community, particularly due to the huge practical and political obstacles to establishing or expanding protected areas on this scale. The new designation of "other effective area-based conservation measures" (OECMs) provides the opportunity for formal recognition of and support for areas delivering conservation outcomes outside the protected area estate. We argue that OECMs are essential to the achievement of big and bold conservation targets such as Half-Earth. But integration of OECMs into the conservation estate requires fundamental changes in protected area planning and how the conservation community deals with human rights and social safeguards issues; it therefore challenges our understanding of what constitutes "conservation". It will only succeed if the key drivers of biodiversity and ecosystem service loss are addressed in the whole planet. A broad, multifaceted and innovative approach, coupled with ambitious targets, provides our best hope yet of addressing complex conservation challenges. (C) 2018 Published by Elsevier B.V.Peer reviewe

The Intersections of Biological Diversity and Cultural Diversity: Towards Integration

There is an emerging recognition that the diversity of life comprises both biological and cultural diversity. In the past, however, it has been common to make divisions between nature and culture, arising partly out of a desire to control nature. The range of interconnections between biological and cultural diversity are reflected in the growing variety of environmental sub-disciplines that have emerged. In this article, we present ideas from a number of these sub-disciplines. We investigate four bridges linking both types of diversity (beliefs and worldviews, livelihoods and practices, knowledge bases and languages, and norms and institutions), seek to determine the common drivers of loss that exist, and suggest a novel and integrative path forwards. We recommend that future policy responses should target both biological and cultural diversity in a combined approach to conservation. The degree to which biological diversity is linked to cultural diversity is only beginning to be understood. But it is precisely as our knowledge is advancing that these complex systems are under threat. While conserving nature alongside human cultures presents unique challenges, we suggest that any hope for saving biological diversity is predicated on a concomitant effort to appreciate and protect cultural diversity

Essential indicators for measuring site‐based conservation effectiveness in the post‐2020 global biodiversity framework

Abstract: Work on the post‐2020 global biodiversity framework is now well advanced and will outline a vision, goals, and targets for the next decade of biodiversity conservation and beyond. For the effectiveness of Protected areas and Other Effective area‐based Conservation Measures, an indicator has been proposed for “areas meeting their documented ecological objectives.” However, the Convention on Biological Diversity (CBD) has not identified or agreed on what data should inform this indicator. Here we draw on experiences from the assessment of protected area effectiveness in the CBD's previous strategic plan to provide recommendations on the essential elements related to biodiversity outcomes and management that need to be captured in this updated indicator as well as how this could be done. Our proposed protected area effectiveness indicators include a combination of remotely derived products for all protected areas, combined with data from monitoring of both protected area management and trends in species and ecosystems based on field observations. Additionally, we highlight the need for creating a digital infrastructure to operationalize national‐level data‐capture. We believe these steps are critical and urge the adoption of suitable protected area effectiveness indicators before the post‐2020 framework is agreed in 2021

What's on the horizon for community-based conservation? Emerging threats and opportunities

Community-based conservation can support livelihoods and biodiversity, while reinforcing local and Indigenous values, cultures, and institutions. Its delivery can help address cross-cutting global challenges, such as climate change, conservation, poverty, and food security. Therefore, understanding trends in community-based conservation is pertinent to setting and implementing global goals. We undertook a horizon scan to prioritize 15 emerging threats and opportunities expected to impact the future effectiveness of community-based conservation. Topics relate to global biodiversity policy; human rights; shifting human geography; inclusion, diversity, equity, and access; conservation finance and income; and economic reforms. Our findings offer guidance on strengthening community-based conservation to achieve global environmental and development goals

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment